ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2016

May 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOTEK PHARMACEUTICALS CORP (ITEK)
CIK: 0001281895
Period of Report: 2016-05-13

Reporting Person: CARROLL J MARTIN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-05-13	Common Stock	P	10000	$9.0294	Acquired	10000	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $8.99 to $9.06, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth.